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Abstract	
	
Diabetes	Mellitus	 (DM)	 is	 one	 of	 the	 chronic	 diseases	 related	 to	 many	 kinds	 of	
drug	related	problems	(DRPs).	Being	a	part	of	the	healthcare	team,	pharmacist	should	be	
of	concern	for	DRPs,	especially	those	which	give	harm	to	the	patients	and	interfere	with	
the	goal	of	therapy.	Medication	reconciliation	is	an	effort	that	can	be	used	by	pharmacist	
to	identify,	avoid,	and	give	solution	to	DRPs.	This	research	aims	to	identify	potential	and	
actual	DRPs	in	diabetic	patients	through	medication	reconciliation	process.		
This	 research	 used	 a	 non‐experimental	 design	 where	 the	 researcher	 intends	 to	
give	a	description	on	DRPs	identified	through	medication	reconciliation	process.	Sample	
in	the	study	were	type	2	DM	patients	who	gave	a	visit	to	a	Primary	healthcare	centre	in	
Bantul,	Yogyakarta	during	August	–	December	2015.	Medication	reconciliation	process	
was	conducted	by	gaining	complete	information	of	drugs/herbs/supplements	that	were	
routinely	consumed	by	the	patients	and	comparing	it	with	newly	prescribed	drugs	at	the	
time	 of	 visit.	 Actual	 and	 potential	 DRPs	 were	 identified	 based	 on	 the	 result	 of	
comparison	and	evaluation	of	patients’	drugs/herbs/supplements	consumption.	
A	number	of	35	type	2	DM	patients	were	included	in	this	research.	Result	showed	
that	82.86	%	of	patients	were	identified	with	actual	and/or	potential	DRPs.	Actual	DRPs	
identified	 were	 inadherence	 (39.39%)	 and	 adverse	 drug	 reaction	 (9.09%),	 while	
potential	DRPs	 identified	were	 adverse	 drug	 reaction	 (15.15%)	 and	 drug	 interactions	
(36.36%).	 Medication	 reconciliation	 resulted	 in	 more	 complete	 information	 useful	 to	
identify	DRPs.	
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1. Introduction	
Diabetes	Mellitus	 (DM)	 is	one	of	 the	chronic	diseases	with	a	high	prevalence	 in	
the	world	including	Indonesia.	The	number	of	DM	patients	worldwide	in	2014	reached	
422	million	adults	which	showed	a	2‐fold	 increase	 from	1980	(WHO,	2016).	Indonesia	
itself	 had	 a	 number	 of	 8.4	million	 diabetes	which	 is	 predicted	 to	 give	 almost	 a	 3‐fold	
increase	 in	 2030	 (Perkeni,	 2011).	 As	 in	 2013,	 the	 Basic	 Health	 Research	 done	 in	
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Indonesia	revealed	a	2.1%	increase	in	prevalency	of	DM	compared	to	1.1%	increase	in	
2007	(Kemenkes,	2013).	
	
A	 high	 prevalence	 in	 DM	 is	 associated	 with	 a	 high	 incidence	 of	 Drug	 Related	
Problems	(DRPs)	among	diabetic	patients.	A	study	on	Type	2	DM	patients	 in	a	tertiary	
hospital	in	Malaysia	resulted	in	406	DRPs	where	91.8%	had	at	least	one	DRP	occurring	
with	potential	drug‐drug	 interaction	as	the	most	 frequent	DRP,	while	another	study	 in	
Nigeria	found	that	there	was	an	average	of	2.1	DRPs	occurring	in	399	diabetic	patients	
with	non‐adherence	as	the	main	problem	(Huri	and	Ling,	2013;	Ogbonna	et	al,	2014).	A	
different	 pattern	 can	 be	 seen	 in	 Indonesian	 hospitals	 where	 the	 common	 DRPs	 in	
diabetes	patients	were	mostly	over	dosage	and	drug‐drug	interaction	(Wahyuni,	2013;	
Sari,	2015;	Marbun,	2016).		
	
The	common	use	of	complementary	and	alternative	medicines	such	as	traditional	
herbs	 can	 also	 be	 related	 to	 DRPs	 in	 diabetic	 patients.	 A	 national	 survey	 showed	 an	
increase	 in	 herb	 usage	 among	 Indonesian	 people	 for	 the	 intention	 of	 self	 medication	
(Supardi,	2003).	Drug	interaction	was	the	most	commonly	DRPs	that	is	associated	with	
CAMs	 usage.	 A	 number	 of	 882	 drug	 –	 CAMs	 interaction	 had	 been	 identified	 where	
around	240	of	them	were	interactions	with	major	significancy	(Tsai	et	al,	2012).	
	
Identification	 of	 DRPs	 as	 one	 of	 the	main	 activities	 of	 a	 pharmacist	 have	 gone	
through	 various	 	 inovation	 in	 order	 to	 provide	 an	 effective	 way	 for	 pharmacist	 to	
conduct	 this	 activity.	 Medication	 reconciliation	 is	 one	 of	 the	 attempt	 to	 identify	 and	
prevent	DRPs	by	gathering	important	information	of	drug	usage	which	eventually	could	
prevent	 medication	 errors	 (Barnsteiner,	 2008).	 This	 study	 was	 conducted	 to	 identify	
actual	and	potential	DRPs	that	occur	in	diabetes	patients	having	their	routine	visit	to	the	
Primary	Healthcare	center.	
	
2. Material	and	Methods	
	
2.1. Study	design	
	
This	study	was	conducted	through	an	observational	or	non‐experimental	design.	
Patients	 meeting	 the	 inclusion	 criteria	 entered	 the	 medication	 reconciliation	 process	
where	the	researcher	obtained	thorough	information	regarding	medication	history	and	
other	 complementary	 and	 alternative	medicines	 (CAMs)	 through	 deep	 interview	with	
the	 patients.	 Medication	 reconciliation	 was	 then	 conducted	 by	 comparing	medication	
information	 from	 patients	 with	 the	 newly	 prescribed	medication	 given	 by	 the	 doctor	
from	their	visit	to	identify	any	drug	related	problems.	
	
2.2. Study	time	and	location	
	
This	 study	 was	 conducted	 in	 a	 Primary	 Healthcare	 Center	 in	 Bantul	 Region,	
Special	 District	 of	 Yogyakarta,	 Indonesia	 where	 DM	 patients	 in	 the	 surrounding	 area	
usually	do	routine	visit	to	the	primary	care	doctor	and	obtain	their	medication	monthly.	
The	study	period	was	from	August	to	December	2015.	
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2.3. Patient	selection	
	
Patients	recruited	for	this	study	had	to	meet	the	inclusion	criteria	determined	by	
the	researcher	as	follows:	patients	above	18	years	old,	agree	to	be	a	research	subject	(by	
fulfillment	 of	 inform	 consent),	 diagnosed	 with	 type	 2	 DM	 for	 a	 minimum	 of	 5	 years.	
Patients	were	excluded	if	they	didn’t	know	or	could	not	describe	the	type	of	medication	
or	CAMs	routinely	consumed	at	home.	
	
2.4. Data	analysis	
	
Identification	 of	 drug	 related	 problems	 was	 done	 by	 comparing	 and	 analyzing	
both	medication	list	from	the	interview	process	and	newly	prescribed	medication	by	the	
doctor.	Identified	DRPs	was	then	classified	according	to	types	of	DRPs	which	consist	of	
actual	and	potential	DRPs.	Actual	DRPs	was	determined	as	DRPs	which	occurred	in	the	
study	 period	 while	 potential	 DRPs	 were	 problems	 that	 were	 identified	 through	
literature	trace	but	had	not	yet	happen	to	the	patient	in	the	study	period.	Each	type	of	
DRPs	was	analyzed	to	gain	result	on	major	DRPs	happening	in	type	2	DM	patients.	
	
3. Results	and	Discussion	
	
3.1. Patient	characteristics	
	
Patients	recruited	in	this	study	were	35	type	2	DM	patients	who	met	the	inclusion	
criteria.	Table	1	describes	the	characteristics	of	patients	in	this	study.	
	
Table	1.	Patients	Characteristic	Distribution	
Characteristic	 Description Percentage	
Gender	 Male 31.43%	
Female 68.57%	
Age	 40	– 50	years	old 14.29%	
51	– 65	years	old 20%	
>65	years	old 65.71%	
Co‐morbids	 Hypertension 76.93%	
Dyslipidemia 7.69%	
Hypertension +	Dyslipidemia 7.69%	
Hypertension +	Hyperuricaemia 7.69%	
 
Based	 on	 the	 gender,	 patients	 in	 this	 study	were	mostly	 female	 (68.57%).	 This	
picture	 in	 line	with	 the	result	 from	the	National	Basic	Health	Research	 in	 Indonesia	 in	
the	 year	 2013	 where	 there	 was	 an	 increase	 in	 the	 number	 of	 female	 DM	 patients	
compared	 with	 male	 patients	 (Kemenkes,	 2013).	 The	 difference	 in	 men	 and	 women	
regarding	 the	 risk	 to	 obtain	 diabetes	 is	 usually	 caused	 by	 several	 factors	 such	 as	
difference	in	body	composition,	 insulin	resistance	and	blood	glucose	 level	which	could	
be	influenced	by	sex	hormones	(Geer	and	Shen,	2009).	
	 Age	 is	one	of	 the	 factors	contributing	 in	 the	prevalence	of	DM.	Aging	has	been	
associated	 with	 the	 risk	 of	 insulin	 resistance	 which	 could	 be	 the	 result	 of	 organ	
dysfunction,	commonly	seen	in	late	adults	(Barbieri	et	al,	2001).	The	result	from	Table	1	
indicates	that	most	of	the	patients	subjected	in	this	study	were	above	65	years	old.	For	
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the	 process	 of	 medication	 reconciliation,	 this	 result	 could	 become	 a	 disadvantage	
because	 difficulty	 in	 interviewing	 these	 kind	 of	 patients,	 moreover	 language	 barriers	
was	also	seen	during	the	process	(most	elderly	patients	in	Java	are	used	to	speaking	in	
Javanese).	
	
	 Looking	 at	 the	 result	 related	 to	 the	 co‐morbids	 of	 the	 patients,	 patients	 were	
mostly	diagnosed	with	diabetes	and	hypertension	(76.93%).	This	is	a	common	finding	in	
the	society.	The	relationship	between	diabetes	and	hypertension	can	be	associated	with	
the	 overlapping	 on	 pathophysiology	 of	 both	 diseases	 which	 is	 usually	 related	 with	
obesity,	inflammation,	oxidative	stress	and	insulin	resistance	(Cheung	and	Li,	2012).	
	
3.2. Drug	usage	pattern	
	
Drug	 related	problems	can	often	be	 seen	 through	 the	pattern	of	drug	usage	 in	
patients,	regarding	the	number	of	drugs	consumed	by	the	patients.	Drug	 interaction	is	
one	of	the	most	common	DRP	that	can	be	recognized	by	knowing	the	amount	of	drugs	
prescribed	 or	 consumed	 by	 patients	 which	 is	 not	 rarely	 found	 in	 diabetes	 patients	
(Smith	et	al,	1969;	Grant	et	al,	2003).	Drug	usage	pattern	in	our	subjects	can	be	seen	in	
Table	2.	
	
Table	2.	Drug	Combination	
Drug	Combination No.	of	Patients	(%)
Single	Drug ‐
2	–	combination	drugs 7 (20%)
3	–	combination	drugs 15 (42.86%)
4	–	combination	drugs 11 (31.43%)
5	–	combination	drugs 2 (5.71%)
Total	 35 (100%)
	
This	study	showed	that	drug	usage	pattern	in	diabetes	patients	was	dominated	
with	 3	 to	 4	 drug	 combination	 which	 could	 consist	 of	 anti	 diabetic	 or/and	 non‐anti	
diabetic	drugs.	This	 result	 is	similar	 to	several	 studies	conducted	 in	United	States	and	
Southern	 India	which	 revealed	an	average	of	4.1	 and	4.77	drugs	combined	 in	diabetic	
and	diabetic	hypertension	patients	respectively	(Grant	et	al,	2003;	Hussain	et	al,	2014).	
The	use	of	many	drug	combinations	must	be	a	concern	to	avoid	the	risk	of	adverse	drug	
reaction.	
	
The	consumption	of	complementary	and	alternative	medicines	was	also	seen	in	
4	of	the	subjects.	These	CAMs	consisted	of	the	following	as	described	in	Figure	1.	
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Figure	1.	Use	of	CAMs	
	
There	were	only	few	subjects	in	this	study	(4	out	of	35	patients)	who	routinely	
consume	 CAMs	 besides	 their	 prescribed	 drugs.	 Based	 on	 the	 interview	 with	 all	 35	
patients,	most	of	them	have	already	stopped	their	CAMs	consumption	when	they	were	
diagnosed	with	diabetes	and	also	had	been	told	by	the	doctor	to	stop	their	CAMs.	
	
Insulin	leaves	is	also	known	as	Yakon	leaves	(Smallanthus	sonchifolius)	which	is	
originated	from	Andes	mountains.	This	herb	is	usually	used	as	a	traditional	medicine	in	
Peru.	 Boiled	 insulin	 leaves	have	 shown	benefit	 for	 diabetes	 condition	 for	 its	 ability	 to	
give	effective	glycemic	control	although	has	not	yet	been	clinically	tested	(Lachman	et	al,	
2003;	 Serra‐Barcelona	 et	 al,	 2014).	 Another	 2	 patients	 in	 this	 study	 consumed	 a	
combination	 of	 turmeric	 and	 tamarind	 decoction	 which	 is	 widely	 consumed	 by	
Indonesian	people	for	centuries.	This	mixture	is	commonly	used	for	dysmennorhae	and	
has	also	been	studied	for	its	antioxidant	effect	as	well	as	other	beneficial	effects	(Melin	
and	Soleha,	2016;	Mulyani,	2014).	The	effect	of	curcumin	(active	compound	in	turmeric)	
on	 blood	 glucose	 level	 has	 been	 studied	 in	 a	 systematic	 review	 and	 resulted	 in	
confirmation	 on	 its	 role	 in	 prevention	 and	 treatment	 for	 diabetes	 and	 associated	
disorders	based	on	animal	model	research.	Unfortunately,	there	is	still	few	clinical	trials	
related	to	this	subject	(Zhang	et	al,	2013).	
	
The	use	of	Japanese	ant	was	seen	in	only	1	patients	in	this	study	by	inserting	the	
ant	in	a	capsule.	Japanese	ant	or	Tenebrio	molitor	is	recently	being	popular	in	Indonesian	
people	for	the	treatment	of	diabetes.	The	effect	of	this	insect	on	hyperglycemic	condition	
had	 been	 studied	 by	 Fauzi	 et	 al	 (2016)	 which	 revealed	 this	 insect’s	 potential	 as	 an	
antidiabetic	agent.		
	
3.3. Drug	related	problems	
	
Drug	related	problems	resulted	from	the	process	of	medication	reconciliation	in	
diabetes	 patients	 were	 classified	 into	 actual	 and	 potential	 DRPs.	 From	 a	 total	 of	 35	
subjects,	 we	 found	 33	 cases	 of	 DRPs	 (actual	 and	 potential)	 in	 29	 patients	 (82.86%)	
which	is	detailed	in	Table	3.	
	
	
Insulin 
leaves
25%
Turmeric 
and 
tamarind
50%
Japanese 
ant
25%
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Table	3.	Identified	Drug‐Related	Problems	
Drug‐Related	Problems DRP	Type No.	of	cases (%)	
Inadherence	 Actual 13 (39.39%)	
Adverse	drug	reaction	 Actual &	Potential 8 (24.24%)
Drug	Interaction	 Potential 12 (36.36%)	
Total	 33 (100%)
	
This	 study	 revealed	 that	 most	 of	 diabetic	 patients	 in	 the	 Primary	 Healthcare	
Center	 did	 not	 comply	 in	 consuming	 medication.	 By	 conducting	 medication	
reconciliaton,	 we	 were	 able	 to	 gather	 information	 on	 how	 the	 patient	 consume	 their	
medication	in	order	to	identify	any	sign	of	inadherence.	
	
3.3.1. Inadherence	
	
Inadherence	 is	 one	 of	 the	 DRPs	 commonly	 seen	 in	 chronic	 disease	 patients	
because	of	 long	 life	 consumption	of	medication.	 Inadherence	 can	be	caused	by	 lack	of	
information	 given	 by	 the	 healthcare	 provider	 on	 how	 to	 consume	 the	 medication	 or	
internal	 factors	 from	 the	 patient	 such	 as	 burden	 in	 routine	 consumption,	misbelief	 in	
medication,	 etc.	 Most	 of	 the	 patients	 in	 the	 study	 was	 inadhere	 by	 not	 routinely	
consuming	 the	 antidiabetic	 medication	 such	 as	 metformin	 and	 glybenclamide.	 The	
importance	 of	 adherence	 in	 diabetes	 patients	 was	 studied	 by	 Yu	 et	 al	 (2010)	 which	
concluded	 that	 medication	 adherence	 may	 reduce	 the	 risk	 for	 microvasculare	
complications	 in	 diabetic	 patients.	 Disease	 and	 medication	 beliefs	 were	 known	 as	
significant	predictors	for	inadherence	(Mann	et	al,	2009)	which	was	also	seen	in	patients	
from	 our	 study.	 These	 factors	 are	modifiable	 and	 should	 be	 a	 concern	 for	 healthcare	
providers	in	order	to	improve	patients’	adherence.	
	
3.3.2. Adverse	drug	reaction	
	
Based	 on	 thourough	 interview	 in	 the	 medication	 reconciliation	 process,	 this	
study	was	able	 to	 identify	 several	 adverse	drug	 reaction	 (ADR)	 that	occured	as	 actual	
ADR	and	potential	ADR.	Figure	2	shows	medication	which	contributed	to	these	ADRs.	
	
	
Figure	2.	Drugs	contributing	to	adverse	drug	reaction	
	
Identification	 of	 ADRs	 in	 diabetes	 patients	 in	 this	 study	 was	 dominated	 by	
potential	 ADRs	 from	 the	 use	 of	 Non‐Steroid	 Antiinflammatory	 Drugs	 (NSAIDs).	 The	
Metformin
33%
NSAIDs
67%
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determination	 as	 potential	 ADR	 was	 due	 to	 routine	 use	 of	 NSAIDs	 in	 the	 patients.	
Patients	 were	 prescribed	 with	 NSAIDs	 as	 analgetics	 to	 reduce	 pain	 caused	 by	 post	
surgery	or	pain	in	foot	or	joint.	The	routine	use	of	NSAIDs	has	been	known	to	give	risk	
on	 gastrointestinal	 irritation	 which	 could	 lead	 to	 gastrointestinal	 bleeding	 (Becker,	
2004).	While	actual	ADR	was	seen	in	patients	consuming	metformin	resulting	in	minor	
side	effects	such	as	nausea	and	diarrhea.	
	
3.3.3. Potential	drug	interaction	
	
Medication	reconciliation	conducted	to	diabetes	patients	in	this	study	resulted	in	
several	 potential	 drug	 interaction	which	did	not	 only	 include	drug	 –	 drug	 interaction,	
but	 also	 drug	–	CAM	 interaction.	Table	 4	describes	 the	 interaction	 identified	 from	 the	
study.	
	
Table	4.	Potential	drug	interaction	
Interaction	type	 Interacting	drugs No.	of	cases Percentage	
Minor	 Hydrochlorothiazide +	glimepiride 1 41,67%	
Furosemide +	metformin 1
Nifedipine +	metformin	 1
Metformin	+	turmeric‐tamarind 2
Moderate	 Diclofenac +	glimepiride 3 50%	
Diclofenac	+	glibenclamide 1
Antacid	+	glibenclamide 1
Glibenclamide +	simvastatin 1
Major	 Amlodipine +	simvastatin 1 8,33%	
	 	 12 100%	
	
Potential	drug	 interaction	 identified	 from	 the	patients	was	mostly	 classified	 as	
minor	 and	 moderate	 interaction	 which	 usually	 don’t	 give	 fatal	 effect	 for	 the	 patients	
although	 still	 need	 consideration	 based	 on	 each	 type	 of	 interaction.	 Drug	 interaction	
with	 major	 significancy	 based	 on	 Tatro	 et	 al	 (2006)	 was	 the	 interaction	 between	
amlodipine	and	simvastatin	which	was	seen	 in	1	patient.	The	effect	of	 this	 interaction	
increased	the	risk	of	toxicity	from	simvastatin	such	as	miopathy	and	rhabdomiolysis	and	
must	be	monitored	closely	(Nishio	et	al,	2005).	
	
Potential	interaction	with	CAMs	was	found	in	2	patients	consuming	turmeric	and	
tamarind	 mixture	 drink	 with	 routine	 use	 of	 metformin.	 The	 hypoglycemic	 effect	 of	
curcumin	in	turmeric	(as	discussed	above)	should	be	a	concern	and	patients	should	be	
educated	to	have	their	blood	glucose	routinely	monitored	to	avoid	hypoglycemia	as	well	
as	understanding	the	symptoms	and	what	to	do	in	case	of	hypoglycemia.	
	
Through	medication	reconciliation	process,	the	study	was	able	to	identify	several	
actual	 and	 potential	 DRPs	 occuring	 in	 diabetes	 mellitus	 patients	 having	 their	 routine	
visit	to	the	Primary	Healthcare	Center	such	as	inadherence,	adverse	drug	reactions	and	
also	 durg	 interactions.	 The	 deep	 interview	 in	 the	 beginning	 has	 led	 to	 a	 more	
comprehensive	 understanding	 on	 how	 patients	 consume	 their	 medication	 and	 also	
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CAMs	usage	other	than	prescribed	drugs	which	contribute	to	a	better	way	on	identifying	
DRPs	compared	to	the	usual	visit	in	a	Primary	Healthcare	Center.	
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